Emsi-New England Dna is categorized under Medical Examinations-Insurance in Rocky Hill, CT .
Emsi-New England Dna was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Examinations-Insurance business, which does work in the B2C market, and is classified as a Medical Examinations-Insurance, under code number 6215111 by the NAICS.
If you are seeking more information, feel free to contact Rob Kloiber, Owner at the company’s single location by writing to 2257 Silas Deane Highway # 3, Rocky Hill, Connecticut CT 06067 or by phoning (860) 436-2549. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Emsi-New England Dna |
Contact Person: | Rob Kloiber, Owner |
Address: | 2257 Silas Deane Highway # 3, Rocky Hill, Connecticut 06067 |
Phone Number: | (860) 436-2549 |
Website Address: | emsict.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical Examinations-Insurance |
SIC Code: | 8099 |
NAICS Code: | 6215111 |
Share This Business: |
Emsi-New England Dna was started in 0 to provide professional Medical Examinations-Insurance under the SIC code 8099 and NAICS code 6215111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Rob Kloiber, Owner for inquiries that concern Emsi-New England Dna by calling the company number (860) 436-2549, as your correspondence is most welcome. Additionally, the physical location of the single location of Emsi-New England Dna can be found at the coordinates 41.66692,-72.64094 as well as the street address 2257 Silas Deane Highway # 3 in Rocky Hill, Connecticut 06067.
For its online presence, you may visit Emsi-New England Dna’s website at emsict.com and engage with its social media outlets through on Twitter and on Facebook.